BioMaje is your operational and strategic partner in the fields of bioproduction, anti-infectives and bacteriophages for biotechnology and pharmaceutical organizations
In the anti-infective sector, BioMaje supports its clients from research to the clinic, with specific international expertise in the field of phage therapy.
Tomorrow, health will have to be personalized, affordable and accessible to all.Discover
Pragmatism, agility, flexibility, and frugality is our motivation.
A WORD FROM THE FOUNDER
"BioMaje came from a continual reflection made during my industrial career. Often, a situation is unblocked, thanks to an external expert who, without a priori, unlocks the trigger. BioMaje is founded on this analytical capacity to provide A solution to THE problem from a new angle."
More than 30 years of experience in startups, innovative SMEs and large groups in R&D,
production and regulatory.
THEY TRUST US
A network of trust, professionals and collaborations.
France Europe Innovation supports the promoters of innovative French or European projects in responding to calls for proposals for public funding programs: Horizon 2020, Eurostars, Eureka, Era-net, BPI, ANR, DGA, etc.
Eligo Biosciences is developing a new class of targeted biotherapeutic agents to selectively intervene on the microbiome.
Augurix markets quality diagnostic tests and especially for the detection of immune protection against the Sars-Cov-2 virus of COVID-19 disease.
Metabolium has developed a proprietary process for the bioproduction of heterotrophic and seleniated microalgae. Its food supplements improve the body's defenses.